Raymond James cuts Cigna to Outperform on lack of near-term catalysts
Raymond James downgraded Cigna Group (CI) from Strong Buy to Outperform and lowered its price target to $320 from $350, citing a lack of near-term catalysts despite an attractive valuation. The firm noted slower growth in Cigna's mature market and ongoing headwinds in its …